Skip to main content
SpringerLink
Log in

Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Barrington SF, Sulkin T, Forbes A, Johnson PW. All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting. Eur J Nucl Med Mol Imaging. 2018;45(2):316–7. https://doi.org/10.1007/s00259-017-3893-z.

    Article  PubMed  Google Scholar 

  2. van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44:4–16. https://doi.org/10.1007/s00259-017-3727-z.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Enilorac B, Lasnon C, Nganoa C, Fruchart C, Gac AC, Damaj G, et al. Does PET reconstruction method affect Deauville scoring in lymphoma patients? J Nucl Med. 2017. https://doi.org/10.2967/jnumed.117.202721.

    PubMed  Google Scholar 

  4. Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood. 2011;118:37–43. https://doi.org/10.1182/blood-2010-12-327767.

    Article  CAS  PubMed  Google Scholar 

  5. Bodet-Milin C, Kraeber-Bodere F, Moreau P, Campion L, Dupas B, Le Gouill S. Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica. 2008;93:471–2. https://doi.org/10.3324/haematol.12013.

    Article  PubMed  Google Scholar 

  6. Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23:4643–51. https://doi.org/10.1200/jco.2005.12.072.

    Article  PubMed  Google Scholar 

  7. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.

    Article  CAS  PubMed  Google Scholar 

  8. Lasnon C, Enilorac B, Popotte H, Aide N. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs). EJNMMI Res. 2017;7:30. https://doi.org/10.1186/s13550-017-0279-y.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17–31. https://doi.org/10.1007/s00259-017-3740-2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276–81. https://doi.org/10.2967/jnumed.116.180406.

    Article  CAS  PubMed  Google Scholar 

  11. Kaalep A, Sera T, Oyen W, Krause BJ, Chiti A, Liu Y, et al. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems. Eur J Nucl Med Mol Imaging. 2017. https://doi.org/10.1007/s00259-017-3853-7.

    PubMed Central  PubMed  Google Scholar 

  12. Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, et al. PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood. 2016;127:1531–8. https://doi.org/10.1182/blood-2015-11-679407.

    Article  CAS  PubMed  Google Scholar 

  13. Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging. 2015;42:2072–82. https://doi.org/10.1007/s00259-015-3128-0.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, François Baclesse Cancer Centre, Caen, France

    Charline Lasnon

  2. INSERM 1199 ANTICIPE, Normandie University, Caen, France

    Charline Lasnon & Nicolas Aide

  3. Nuclear Medicine Department, University Hospital, Caen, France

    Blandine Enilorac & Nicolas Aide

Authors
  1. Charline Lasnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Blandine Enilorac
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicolas Aide
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas Aide.

Ethics declarations

Conflicts of interest

N. Aide received a research grant from Siemens for the work described in reference 13. Other authors declare no conflicts of interest related to this submission.

Ethical approval

According to European regulations, French observational studies without any additional therapy or monitoring procedures do not need ethics approval. Nonetheless, approval to collect data for results presented here was obtained from the National Committee for Data Privacy (registration no. 2084622v0).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lasnon, C., Enilorac, B. & Aide, N. Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”. Eur J Nucl Med Mol Imaging 45, 878–881 (2018). https://doi.org/10.1007/s00259-018-3938-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-3938-y

Search

Navigation